Nasdaq:US$15.71 (-1.08) | HKEX:HK$24.55 (-0.40) | AIM:£2.35 (-0.01)
News & Presentations
Previous Article   |   Next Article
Presentations | 6 Jun 2022

ASCO2022: Surufatinib in US Patients with Soft Tissue Sarcoma